About
What We Do
Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.
Mission Statement
To develop early-stage pharmaceutical and medical device assets that address vital unmet medical needs.
Our Approach
Our approach to commercializing academic research complements the traditional paths of out-licensing the technology to industry or spinning it out as a standalone VC-funded startup. In our hybrid approach, Fannin serves as both the management team and the early investor, collaborating with the academic inventors to advance the technology, leveraging grant funding when appropriate. We evolved this approach as a way to address the biotech development gap in places, like Houston, that have a powerful research engine, but lack the critical mass of commercialization seen in the biotech hubs of Boston and San Francisco. Since inception, Fannin has brought in ~35 programs, of which ~15 are active including three in the clinic. We have had ~$245 million invested across our programs of which ~$73 million was grant funding, with the rest from investors. Learn More
More Information?
Contact our Business Operations Manager, Serena Miggins, to learn more about Fannin.
Our Inventors and Collaborators
Fannin Innovation Studio is proud to collaborate with organizations, inventors, and collaborators that share Fannin’s mission and values. Fannin has established collaborations in various specialties across the nation.
Roberto Adachi
MD ANDERSON CANCER CENTER
Michael Belfort
BAYLOR COLLEGE OF MEDICINE
Achu Byju
TEXAS A&M UNIVERSITY
Roy F. Chemaly
MD ANDERSON CANCER CENTER
Seong H. Cho
UNIVERSITY OF SOUTH FLORIDA
William E. Cohn
TEXAS HEART INSTITUTE
David B. Corry
BAYLOR COLLEGE OF MEDICINE
Reynolds M. Delgado
TEXAS HEART INSTITUTE
Burton Dickey
MD ANDERSON CANCER CENTER
Scott K. Durum
NATIONAL CANCER INSTITUTE
Jimmy Espinoza
TEXAS CHILDREN’S HOSPITAL
Scott E. Evans
MD ANDERSON CANCER CENTER
David Gorenstein
UNIVERSITY OF HOUSTON
Balakrishna Haridas
ETHICON, J & J MEDICAL DEVICES
Magnus Höök
TEXAS A&M UNIVERSITY
Corey Hopkins
UNI. OF NEBRASKA MEDICAL CENTER
Sebastian Johnston
IMPERIAL COLLEGE LONDON
John Morgan Knight
BAYLOR COLLEGE OF MEDICINE
Chester Koh
TEXAS CHILDREN’S HOSPITAL
Andras Lacko
UNIVERSITY OF NORTH TEXAS
Duncan Maitland
TEXAS A&M UNIVERSITY
Ajay Sheshadri
MD ANDERSON CANCER CENTER
Anil K. Sood
MD ANDERSON CANCER CENTER
Eric S. Schafer
TEXAS CHILDREN’S HOSPTIAL
Kara Toman
TEXAS CHILDREN’S HOSPITAL
Michael Tuvim
MD ANDERSON CANCER CENTER
Sara Ward
TEMPLE UNIVERSITY